| |
 |
Delhi poll results, shaky earnings among top 5 factors weighing on Sensex Nifty also slipped below its crucial psychological level of 8550, weighed down by losses in capital goods, auto, powe... |
Why markets are spooked over likely AAP government in Delhi Almost all exit polls have predicted a majority for the Aam Aadmi Party (AAP), giving it 53 seats in the 70-member De... |
Grexit, China growth fears weigh on European assets Having won little support for debt relief last week, Tsipras' defiant speech on Sunday has upped the ante in a stando... |
| |
| |
| |
| FROM THE NEWSPAPER |
| L&T Q3 net profit rises 9% at Rs 867 crore The company had clocked Rs 796.66 crore net profit in the October-December quarter of last fiscal, it said in a BSE f... |
| Apollo Tyres drops nearly 17% as Q3 net profit tumbles Net sales of the company declined to Rs 3,091.55 crore for the third quarter, as against Rs 3,475.12 crore during the... |
| Wockhardt gains 4%; Citigroup upgrades to 'buy' Wockhardt's earnings could double, even on conservative assumptions, once it resolves issues at two plants under impo... |
| For Gujarat State Fertilizers and Chemicals, worst is all but over GSFC operates in fertilisers and industrial chemical segments. The fertiliser division is doing reasonably well now.... |
| Gold prices plunge by Rs 410 on weak global cues, low demand Traders said apart from slackened demand at current levels from jewellers and retailers, a weak global trend mainly p... |
MORE LINKS:Gainers | Losers | Movers | Only Buyers | Only Sellers | Surging Volumes | Indices |
|
| More Newsletters |
|
| |  | ET Mutual Fund A weekly round-up of the top news and views from the mutual fund industry. | |  | | |  | Wealth Weekly news on personal finance, stocks, property, gold, tax planning and more. | |  | |
| |
| |
To ensure delivery directly to your inbox, please add etnotifications@indiatimes.com to your address book today. If you are having trouble viewing this newsletter, please click here |
| To unsubscribe or edit your subscriptions please click here |
No comments:
Post a Comment